Screening Contrast-Enhanced Mammography as an Alternative to MRI
NCT: NCT04764292 · COMPLETED
Brief Summary
There are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative to MRI for screening that uses updated standard mammography equipment to obtain low- and high-energy images after intravenous injection of iodinated contrast (as used in CT scanning). The investigators seek to validate screening CEM as an alternative to screening MRI.
Frequently Asked Questions
What is Screening Contrast-Enhanced Mammography as an Alternative to MRI?
Screening Contrast-Enhanced Mammography as an Alternative to MRI is a clinical trial registered under NCT04764292. Current status: COMPLETED.
What is the status of NCT04764292?
The current status of NCT04764292 (Screening Contrast-Enhanced Mammography as an Alternative to MRI) is: COMPLETED.
When did Screening Contrast-Enhanced Mammography as an Alternative to MRI start?
Screening Contrast-Enhanced Mammography as an Alternative to MRI started on 2021-02-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.